Fabrizio Cantini
- Rheumatology top 0.05%
- Rheumatoid Arthritis Research and Therapies 69
- Spondyloarthritis Studies and Treatments 67
- Systemic Lupus Erythematosus Research 25
- Otitis Media and Relapsing Polychondritis 18
- Genetics top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Vasculitis and related conditions 27
- Hematology top 1%
- Autoimmune and Inflammatory Disorders Research 32
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis 32
-
- Ocular Diseases and Behçet’s Syndrome 20
Fabrizio Cantini
170 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Rheumatology 4.8k
- Genetics 1.3k
- Pulmonary and Respiratory Medicine 3.1k
- Hematology 1.0k
- Immunology 1.8k
Countries citing papers authored by Fabrizio Cantini
This map shows the geographic impact of Fabrizio Cantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Cantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Cantini more than expected).
Fields of papers citing papers by Fabrizio Cantini
This network shows the impact of papers produced by Fabrizio Cantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Cantini. The network helps show where Fabrizio Cantini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fabrizio Cantini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 7 | |
| 5 | 2020 | 28 | |
| 6 | 2020 | 57 | |
| 7 | The Nocebo Effect in Rheumatology: An Unexplored Issue. | 2020 | 4 |
| 8 | 2020 | 4 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 104 | |
| 14 | A national survey on the management of psoriatic arthritis using the Delphi method. | 2017 | 3 |
| 15 | Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study. | 2016 | 11 |
| 16 | Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica. | 2010 | 14 |
| 17 | 2009 | 14 | |
| 18 | Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. | 2000 | 35 |
| 19 | Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging. | 1998 | 58 |
| 20 | 1995 | 43 |
About Fabrizio Cantini
Fabrizio Cantini is a scholar working on Rheumatology, Hematology and Ophthalmology, having authored 173 papers that have together received 7.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (69 papers), Spondyloarthritis Studies and Treatments (67 papers), Autoimmune and Inflammatory Disorders Research (32 papers), Psoriasis: Treatment and Pathogenesis (32 papers), Vasculitis and related conditions (27 papers), Systemic Lupus Erythematosus Research (25 papers), Ocular Diseases and Behçet’s Syndrome (20 papers) and Otitis Media and Relapsing Polychondritis (18 papers). The work is most often cited by research in Rheumatology (4.8k citations), Genetics (1.3k citations) and Pulmonary and Respiratory Medicine (3.1k citations). Fabrizio Cantini has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Carlo Salvarani, Luigi Boiardi, Gene G. Hunder, Laura Niccoli, Ignazio Olivieri, Angela Padula, Delia Goletti, Carlotta Nannini, Pierluigi Macchioni and Emanuele Cassarà. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.